HighGravityDataMicrochip Technology — Aug 7, 2025 release
Fiscal 2026 first-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000827054-25-000132
Showing in the filing
Capital expenditures
“at or below $100 million”
Period
FY2026
Measure
Company-defined measure
Source
Prose
All guidance in this release · 27
Net sales for Q2 FY2026
“$1.130 billion plus or minus $20.0 million”
Sequential net sales growth at midpoint for Q2 FY2026
“approximately 5.1% sequential growth at the midpoint”
Quarterly cash dividend on common stock for Q2 FY2026
“45.5 cents per share”
Quarterly dividend
“45.5 cents per share”
Quarterly cash dividend on 7.50% Series A Ma… for FY2025
“$18.750 per share (which represents $0.9375 per depositary share)”
Quarterly cash dividend on 7.50% Series A Ma…
“$18.750 per share”
GAAP Gross Profit (% of net sales) for Q2 FY2026
“54.3% to 56.2%”
Non-GAAP Gross Profit (% of net sales) for Q2 FY2026
“55.0% to 57.0%”
GAAP Operating Expenses (% of net sales) for Q2 FY2026
“47.4% to 48.0%”
Non-GAAP Operating Expenses (% of net sales) for Q2 FY2026
“32.4% to 32.8%”
GAAP Operating Income (% of net sales) for Q2 FY2026
“6.3% to 8.8%”
Non-GAAP Operating Income (% of net sales) for Q2 FY2026
“22.2% to 24.6%”
Other Expense, net (GAAP) for Q2 FY2026
“$54.7 to $55.3 million”
Other Expense, net (Non-GAAP) for Q2 FY2026
“$54.5 to $55.5 million”
Income Tax Provision (GAAP) for Q2 FY2026
“$10.2 to $23.4 million”
Income Tax Provision (Non-GAAP) for Q2 FY2026
“$18.1 to $21.7 million”
Net income (GAAP) for Q2 FY2026
“$4.4 to $23.4 million”
Dividends on Series A Preferred Stock (GAAP) for Q2 FY2026
“$(27.8) million”
Net (loss) income attributable to common sto… for Q2 FY2026
“$(23.5) to $(4.5) million”
Net (loss) income attributable to common sto… for Q2 FY2026
“$172.8 to $206.7 million”
Diluted Common Shares Outstanding (GAAP) for Q2 FY2026
“Approximately 539.8 million shares”
Diluted Common Shares Outstanding (Non-GAAP) for Q2 FY2026
“Approximately 568.3 to 569.3 million shares”
Diluted net (loss) per common share (GAAP) for Q2 FY2026
“$(0.04) to $(0.01)”
Diluted net (loss) per common share (Non-GAAP) for Q2 FY2026
“$0.30 to $0.36”
Capital expenditures for Q2 FY2025
“between $35 million and $40 million”
Capital expenditures for FY2026
“at or below $100 million”
Assumed average Microchip stock price (for d… for Q2 FY2025
“between $65 and $75 per share”
Exhibit 99.1 · the passage around this item
… earlier in the release
(5) Our GAAP guidance excludes the impact of any potential charges related to our ongoing evaluation of restructuring activities. Capital expenditures for the quarter ending September 30, 2025 are expected to be between $35 million and $40 million. Capital expenditures for all of fiscal 2026 are expected to be at or below $100 million. Consistent with the slow macroeconomic environment in fiscal 2025, we have paused most of our factory expansion actions and reduced our planned capital investments through fiscal 2026. However, we are adding capital equipment to selectively expand our production capacity and add research and development equipment. Under the GAAP revenue recognition standard, we are required to recognize revenue when control of the product changes from us to a customer or distributor. We focus our sales and marketing efforts on creating demand for our products in the end markets we serve and not on moving inventory into our distribution network. We also manage our manufacturing and supply chain operations, including our distributor relationships, towards the goal of having our products available at the time and location the end customer desires. - - more - - Microchip Technology Reports First Quarter Fiscal 2026 Financial Results Page 5 Use of Non-GAAP Financial Measures: Our non-GAAP adjustments, where applicable, include the effect of share-based compensation, restructuring charges, expenses related to our acquisition activities (including intangible asset amortization, severance, and other rest
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.